Uflex FY26: Profits Back to Positive, Multiple Still Proving Itself

General information and entertainment, not investment advice. The author is not a SEBI-registered adviser or research analyst. No recommendation, no promised returns. Markets carry risk including loss of capital. Figures may not be current. Consult a registered adviser before acting.

1 — At a Glance

Uflex returned to profitability in FY26 after a loss-making FY25, with net profit of ₹142 crore—but that number masks the scale of recovery elsewhere. Revenue grew 12.4% to ₹15,036 crore, while operating profit climbed 35% to ₹1,860 crore (from ₹1,387 crore in FY25). EBITDA margin expanded 70 basis points to 12.8%.

Yet the stock trades at 9.1x earnings, a discount to peers averaging 21.2x. The company is loading up capex on higher-margin aseptic and recycled plastic, banking that these projects—not film spreads—drive the next phase.

The market appears to be waiting. The question hanging over ₹417 is whether executing new capacity adds durability to profit, or just cycles the mix without fixing the core tension.

2 — Introduction

Uflex sits in global flexible packaging, a business split between commodity films and branded solutions. The company operates 17 facilities across 9 countries and sells into food, beverage, pharma, and pet food. Geographically, it’s now 57% international and 43% India.

FY26 was choppy. Raw material costs surged and fell in waves. Tariff uncertainty in the US dragged film demand. European customers deferred buys. Yet India’s FMCG held up, and demand in the Americas rebounded hard as the US government shutdown ended and post-holiday restocking kicked in.

Management has reframed the story. It’s no longer just a commodity films player buying capacity at scale—it’s a portfolio upgader tilting into aseptic liquid packaging, recycled polyester (rPET), and specialty films. New projects in Egypt, Mexico, and Noida are live or near-live.

Rajesh Bhatia, the CFO, left in early February. That’s worth noting for continuity, though not fatal.

3 — Business Model: WTF Do They Even Do?

The headline: we make the plastic wrap your food comes in, the pouch for your laundry detergent, the carton your juice sits in.

Revenue splits three ways:

Packaging Films (BOPET, CPP, PE)—commodity films, high volume, tight margins, vulnerable to raw material swings. FY26 revenue ₹8,319 crore (55% of total). Volumes in films fell 1% to 498,034 MT due to tariff delays and European softness.

Packaging Solutions—the shift play. Aseptic liquid cartons (juice, milk, soy milk), flexible pouches, holography, specialty laminates. FY26 revenue ₹5,431 crore (36% of total). Volumes grew 5% to 151,755 MT, outpacing films. Margins here are healthier.

Engineering, Chemicals, and Others—niche. 7% of revenue.

The geographic split reveals tilt. India (43% of sales) faces FMCG demand moderation. Americas (19%) rebounded. Europe (17%) stayed under pressure. Middle East & Africa (14%) spiked on Egypt sourcing benefits.

Capacity utilization was uneven across sites. India ran 66%, Dubai 66%, Poland 69%, Hungary at 103% (over-clocked), USA at 103%, Mexico 84%, Egypt 93%. The company isn’t constrained globally; pockets are running hot while others have slack.

4 — Financials Overview

Figures are consolidated, in ₹ crore.

Recovery is real: the company flipped from a ₹691 crore loss in FY25 to a ₹142 crore profit in FY26. It’s not a roaring win—PAT margin sits at just 0.9%—but direction matters. The EBITDA bounce is the truer signal: operating profit jumped ₹473 crore.

Revenue growth was driven partly by volume (sales volume +0.4% to 649,789 MT) and partly by a mix shift toward higher-priced Packaging Solutions. Other income was a drag: negative ₹51 crore in FY26 (management took a ₹745 crore hit in FY25 due to forex losses).

Interest expense climbed to ₹777 crore (from ₹698 crore in FY25) as debt ballooned to fund capex. Depreciation rose to ₹787 crore.

Q4 FY26 Snapshot (3 months, unconsolidated quarterly data):

Sales: ₹4,056 crore (+6.3% QoQ, +13.6% from Q4 FY25). Operating profit: ₹584 crore (14.4% OPM—the highest in 14 quarters per the concall). Net profit: ₹196 crore (best quarter in recent memory).

But management flagged this as a one-off. In Q4, raw material costs spiked, but the company raised prices faster than costs rose, locking in temporary spreads. This dislocation was already mean-reverting into Q1 FY27. So don’t project Q4 margins forward.

5 — Market Expectations & Historical Multiples

This section describes how the market is currently pricing the company and how that compares with its own history and peer group. It is descriptive, not predictive.

The market currently pays 9.1x earnings here, against a peer median of 21.2x. The discount is vast, and rooted in performance: Uflex’s ROE of 4.3% trails the peer average of 10.96%, and ROCE of 7% sits a full 500 basis points below the peer set’s